Examination of the kinetics of immune complex formation for these hypertriglyceridemic specimens showed that complex formation occurred rapidly the first 30 s of the reaction and then decreased with time. This effect was eliminated by removing lipids from the serum by centrifugation. We conclude that, as for ape A-I (6), grossly lipemic specimens should be centrifuged to avoid falsely low values caused by sample turbidity and displacement of serum water by chylomicrons. With this treatment for hypertriglyceridemia, the method is suitable for use in a clinical laboratory.
We evaluated three different methods for measuring lactate dehydrogenase (EC 1.1.1.27) isoenzyme LD-1 activityagarose gel electrophoresis and two immunoassays, Isomune-LD (Roche) and LD-1 Immuno (Seragen)-in patients' samples for which measurement of creatine kinase-MB was ordered. Regression analyses of the comparisons gave the following results: LD-1 (%) from lsomune-LD (y) vs electrophoresis (x) (n = 51), y = 1.05x + 1.99, r = 0.92; LD-1 (%) from LD-1 Immuno a.') vs electrophoresis (n = 27), y = 1.05x + 3.94, r = 0.88; LD-1 (%) from LD-1 Immuno (y) vs Isomune-LD (x) (n = 41), y = 1.06x + 0.48, r = 0.95. Comparison by Student's paired t-test yielded significant differences between the mean values by electrophoresis and both Isomune-LD (P <0.005) and LD-1 Immuno (P <0.001), but no significant difference between the two immunoassays (P >0.2). Analyzing these results by the overlap index, we conclude that electrophoresis shows the best clinical correlation followed, in order, by the lsomune-LD and the LD-1 Immuno methods. Both immunoassays are simpler and more rapid than electrophoresis, but in our hands the Isomune-LD method demonstrated greater precision and better correlation with electrophoretic values. infarction is well established (1) (2) (3) (4) . Electrophoresis has been the technique most widely used for this purpose (5,6), but is complex, tedious, and time-consuming, requiring expensive equipment and highly skilled technologists. Recent development of immunoassays for the isoenzymes of LD has rekindled interest in the measurement of isoen.zyme LD-1 in patients with acute myocardial ischemic syndromes (7) (8) (9) (10) . The immunoseparation methods appear to be more sensitive and specific than electrophoresis, with additional advantages of procedural simplicity, as well as rapidity, making these techniques more routinely applicable (10) (11) (12) (13) . We undertook this study to compare results by two immunoassays for LD-1-the Isomune-LD (Roche Diagnostic Systems, Nutley, NJ) and the LD-1 Immuno (Seragen, Indianapolis, IN)-with those by the classical electrophoretic method.
Materials and Methods

Specimens
Specimens from 51 patie!its for whom a creatine kinase-MB (CK-MB) assay had been ordered were kept at room temperature and assayed for total LD activity, LD isoenzymes by electrophoresis, LD-1 (%) by Isomune-LD (Roche) (n = 51), and LD-1 (%) by LD-1 Immuno (Seragen) (n = 41). The medical records of these 51 patients were reviewed.
Procedures LD-1 assay by elect rophoresis. LD isoenzymes were separated on agarose gels (Beckman Instruments, Brea, CA). activity, we added 50 zL of goat anti-LD-1 antiserum to 200 L of serum, incubated at ambient temperature for 5 mm, and centrifuged (1000 x g, 5 mm). We then measured LD-1 activityin the supernate by the same method used to determine total LD activity, in either the Abbott-VP or the Astra-8E automated analyzers. Final LD activity was calculated by multiplying the activity in the supernate by 2.25. LD-1 Immuno separation set. After determining total LD activity, we added 40 jL of mammalian anti-human LD-M subunit antibody to 200 tL of serum and incubated for 2 to 5 mm. We then added 40 L of a solution of anti-mammalian IgG antibody to the treated serum, followed immediately by 200 pL of polyethylene glycol precipitating reagent. After an additional 5 mm incubation, the suspension was centrifuged (1000 x g, 5 mm) and the resulting supernate assayed for LD-1 activity by using the Abbott-VP analyzer. Final LD activity was calculated by multiplying the activity in the supernate by 2.64.
Results and Discussion
Analytical Results
Results from the three methods were compared by using standard least-squares analysis with correlations determined by the product-moment method of Pearson (14) . 
In half the cases studied, the LD-1 Immuno method produced larger values for LD-1% than did the
Isomune-LD method. The two immunoseparation methods correlated with each other best, with poorer correlation being observed between electrophoresis and either the Isomune-LD method or the LD-1 Immuno method-findings in essential agreement with those of Fike (10) and Au et al. (13) . A smaller intercept of 1.94 for Isomune-LD vs 3.94 for LD-1 Immuno favors the Isomune-LD method as having slightly less bias than electrophoresis.
Significant differences by Student's paired t-test were observed between the mean values from electrophoresis and both Isomune-LD (P <0.005) and LD-1 Immuno (P <0.001), but no significant difference was seen between the Isomune-LD and LD-1 Immuno results (P >0.2).
Day-to-day precision studies indicated significantly better performance for Isomune-LD (SD = 3.7%, mean LD-1 = 45.2%, CV = 8.3%) than for LD-1 Immuno (SD = 7.3%, mean LD-1 = 54.1%, CV = 13.5%) as judged by anFtest (P <0.005). Results for the electrophoresis method were: SD = 1.9%, mean LD-1 = 23.0%, CV = 8.3%, but because these values were derived from a quality-control material having a significantly different mean value from those used for the immunoassay methods, we could not readily compare the variances by an F test.
Clinical Results
To interpret test results, we used the reference range established by the manufacturer ofeach method. Generally, all three methods yielded similar clinical predictions, but differences in clinical interpretations were observed between Isomune-LD and electrophoresis in 10% (5/51), between LD-1 Immuno and electrophoresis in 4% (1/27), and between Isomune-LD and LD-1 Immuno in 7% (3/41) of the results obtained (Table 1) . Of the first six cases, no. 1 was diagnosed as atypical chest pain of noncardiac origin and showed no increase of CK, LD, or CK-MB; no. 2 experienced an anterior septal myocardial infarction with a value for CK at admission of 1568 U/L and CK-MB of only 44 UIL; no. 3 presented with chronic obstructive lung disease and normal serially determined enzyme activities; no. 4 had a small perioperative infarct secondary to mitral valve and aortic valve replacement; no. 5 was diagnosed as having unstable angina with a possible perioperative myocardial infarction as a result of bypass surgery, and had significantly increased CK, LD, and CK-MB; and no. 6, who underwent partial gastrectomy, had increases of CK and LD thought to be due to intramuscular injections and no increase in CK-MB.
Although the use ofdifferent assay methods ledto different clinical interpretations, in these six cases, these differences were considered marginal in patients 1, 4, 5, and 6, the results being borderline (within 10% to 15% of the upper reference limit) by one of the methods. These discrepancies may also be attributable in part to the wide variation in the reference ranges of the different methods. In these six cases, electrophoresis was a correct predictor two-thirds of the time (4/6), Isomune-LD half of the time (3/6), and LD-1 Immuno only a third of the time (1/3).
To further evaluate the clinical utility of each method, we computed the overlap index of Hartz (15) . This nonparametric rank-order statistic provides a relative measure of the degree of overlap of test results for the normal and abnormal patient populations studied, ranging from 0 for no overlap to 1 for identical population medians. We selected this test as an alternative to receiver operating characteristic (ROC) curve analysis because the latter becomes increasingly unreliable as the sample size decreases (16) . The index values obtained were 0.81 for LD-1 Immuno (Seragen), 0.58 for Isomune-LD (Roche), and 0.42 for electrophoresis, indicating that in this particular group of patients electrophoresis showed the best discriminating ability.
We conclude that the two immunoassays are generally analytically comparable and are simpler and more rapid than electrophoresis but in this study neither was as reliable a diagnostic predictor as electrophoresis.
Of the two immunoassays, we found the Isomune-LD procedure to be more reliable. Better correlation to electrophoresis and better precision also favor the Isomune-LD over the LD-1 Immuno method. Although the statistical difference between the two immunoassays and electrophoresis was significant, most patients showed no difference in clinical interpretation of the results.
